Similar Articles
391 Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
392 Multicenter evaluation of recurrence in endoscopic submucosal dissection and endoscopic mucosal resection in the colon: A Western perspective
393 Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1
394 Biliary complications after liver transplantation: A computed tomography and magnetic resonance imaging pictorial review
395 Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
396 Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
397 Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report
398 Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
399 Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
400 Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA